These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 35567903)
1. A pilot study using proximity extension assay of cerebrospinal fluid and its extracellular vesicles identifies novel amyotrophic lateral sclerosis biomarker candidates. Sjoqvist S; Otake K Biochem Biophys Res Commun; 2022 Jul; 613():166-173. PubMed ID: 35567903 [TBL] [Abstract][Full Text] [Related]
2. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis. Collins MA; An J; Hood BL; Conrads TP; Bowser RP J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960 [TBL] [Abstract][Full Text] [Related]
3. Saliva and Saliva Extracellular Vesicles for Biomarker Candidate Identification-Assay Development and Pilot Study in Amyotrophic Lateral Sclerosis. Sjoqvist S; Otake K Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982312 [TBL] [Abstract][Full Text] [Related]
4. Analysis of Cerebrospinal Fluid Extracellular Vesicles by Proximity Extension Assay: A Comparative Study of Four Isolation Kits. Sjoqvist S; Otake K; Hirozane Y Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321992 [TBL] [Abstract][Full Text] [Related]
5. Extracellular Vesicles as Potential Biomarkers in Amyotrophic Lateral Sclerosis. Barbo M; Ravnik-Glavač M Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833252 [TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicles and amyotrophic lateral sclerosis: from misfolded protein vehicles to promising clinical biomarkers. Gagliardi D; Bresolin N; Comi GP; Corti S Cell Mol Life Sci; 2021 Jan; 78(2):561-572. PubMed ID: 32803397 [TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal Fluid Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis. Costa J; Gromicho M; Pronto-Laborinho A; Almeida C; Gomes RA; Guerreiro ACL; Oliva A; Pinto S; de Carvalho M Diagnostics (Basel); 2021 Jul; 11(7):. PubMed ID: 34359293 [TBL] [Abstract][Full Text] [Related]
17. Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis. Oeckl P; Weydt P; Thal DR; Weishaupt JH; Ludolph AC; Otto M Acta Neuropathol; 2020 Jan; 139(1):119-134. PubMed ID: 31701227 [TBL] [Abstract][Full Text] [Related]
18. Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Kasai T; Tokuda T; Ishigami N; Sasayama H; Foulds P; Mitchell DJ; Mann DM; Allsop D; Nakagawa M Acta Neuropathol; 2009 Jan; 117(1):55-62. PubMed ID: 18989684 [TBL] [Abstract][Full Text] [Related]
19. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245 [TBL] [Abstract][Full Text] [Related]
20. Proteomic insights into extracellular vesicles in ALS for therapeutic potential of Ropinirole and biomarker discovery. Kato C; Ueda K; Morimoto S; Takahashi S; Nakamura S; Ozawa F; Ito D; Daté Y; Okada K; Kobayashi N; Nakahara J; Okano H Inflamm Regen; 2024 Jul; 44(1):32. PubMed ID: 38997748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]